Current controversies in the treatment of localized prostate cancer

In the prostate-specific antigen (PSA) era, most prostate cancers (PCa) are diagnosed in alocalized stage and aplethora of therapeutic options are warranted in different clinical settings and disease stages of localized PCa. In the current narrative review, we give an overview of the current controversies in the therapeutic landscape of localized PCa and focus on organ-sparing approaches, percutaneous radiotherapy, brachytherapy as well as retropubic and robot-assisted prostatectomy by summarizing studies that have been published within the last two years.